A Joint Model for Vitamin K-Dependent Clotting Factors and Anticoagulation Proteins.

about

Response to R-warfarin anticoagulant effect.A factor VII-based method for the prediction of anticoagulant response to warfarin

P2860

Q48361252-7275E53B-0E8C-4950-85CA-C8E5AF9BDE7A Q58786914-374100FB-869E-48A7-859E-37D4ECA3EEC0

P2860

A Joint Model for Vitamin K-Dependent Clotting Factors and Anticoagulation Proteins.

Item

http://www.wikidata.org/entity/Q38730441

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

A Joint Model for Vitamin K-Dependent Clotting Factors and Anticoagulation Proteins.

@en

type

Item

label

A Joint Model for Vitamin K-Dependent Clotting Factors and Anticoagulation Proteins.

@en

prefLabel

A Joint Model for Vitamin K-Dependent Clotting Factors and Anticoagulation Proteins.

@en

P1476

A Joint Model for Vitamin K-Dependent Clotting Factors and Anticoagulation Proteins.

@en

P2093

Daniel F B Wright

http://www.w3.org/2001/XMLSchema#string

Geoffrey K Isbister

http://www.w3.org/2001/XMLSchema#string

P2860

Future of coagulation factor replacement therapy

Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models.

Clinical and genetic determinants of warfarin pharmacokinetics and pharmacodynamics during treatment initiation

Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range.

STUDIES ON THE COUMARIN ANTICOAGULANT DRUGS: THE PHARMACODYNAMICS OF WARFARIN IN MAN.

Clinical pharmacokinetics and pharmacodynamics of warfarin. Understanding the dose-effect relationship.

Disposition of warfarin enantiomers and metabolites in patients during multiple dosing with rac-warfarin.

A warfarin induction regimen for out-patient anticoagulation in patients with atrial fibrillation.

A comprehensive model for the humoral coagulation network in humans.

Acquired deficiencies of protein S. Protein S activity during oral anticoagulation, in liver disease, and in disseminated intravascular coagulation

P2888

s40262-017-0541-5

P304

1555-1566

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40262-017-0541-5

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Robert Campbell Tait

Stephen B. Duffull

Qing-Xi Ooi

P577

2017-04-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1084806753

http://www.w3.org/2001/XMLSchema#string

P698

28409488

http://www.w3.org/2001/XMLSchema#string

P921

vitamin K

anticoagulation

A Joint Model for Vitamin K-Dependent Clotting Factors and Anticoagulation Proteins.

about

P2860

P2860

A Joint Model for Vitamin K-Dependent Clotting Factors and Anticoagulation Proteins.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921